Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart disease
Pharma
Novartis pads case for broader use of heart med Leqvio
With a positive phase 3, Novartis aims to apply cholesterol-lowering Leqvio across the "full spectrum" of atherosclerotic cardiovascular disease.
Zoey Becker
Aug 28, 2024 11:29am
Novartis tops docs' ranking of heart disease drug makers
May 7, 2024 4:30pm
Medtronic finds women face gap in screening for aortic stenosis
Apr 8, 2024 10:30am
Abbott kicks off new heart health campaign with Damar Hamlin
Oct 31, 2023 10:15am
Lexicon poaches BMS' Tom Garner as new commercial lead
Oct 10, 2023 9:45am
Alnylam wins expert backing for Onpattro in rare heart disease
Sep 13, 2023 5:30pm
